Camden Property Trust vs Transcontinental Realty Investors
CPT and TCI side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CPT and TCI compare
Camden Property Trust is the larger company, worth 24 times as much as Transcontinental Realty Investors ($9.9B against $413M).
On earnings, Camden Property Trust is cheaper: it trades at 32.5× trailing earnings, against 50.1× for Transcontinental Realty Investors.
Camden Property Trust grew revenue faster over the last twelve months (56.8% versus 5.3% for Transcontinental Realty Investors).
Camden Property Trust keeps more of each dollar of sales as profit, with a net margin of 2486% compared with 16.1% at Transcontinental Realty Investors.
Camden Property Trust pays a dividend yielding 4.3%; Transcontinental Realty Investors does not pay one.
Camden Property Trust scores higher on the StockData Score (11 against 6 for Transcontinental Realty Investors), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CPT | TCI |
|---|---|---|
| Size and price | ||
| Market cap | $9.9B | $413M |
| Share price | $98.01 | $47.06 |
| Change, 1 year | −4.5% | 4.8% |
| Change, 5 years | −41.3% | 20.0% |
| Beta (5Y) | 0.14 | −0.70 |
| Employees | 1,640 | – |
| StockData Score | ||
| Total score | 11 (better) | 6 |
| Valuation score | 1 | 1 |
| Growth score | 3 | 3 |
| Performance score | 3 (better) | 2 |
| Health score | 2 (better) | 0 |
| Dividend score | 2 (better) | 0 |
| Valuation | ||
| P/E | 32.5× (better) | 50.1× |
| P/S | 751× | 8.2× (better) |
| P/B | 2.6× | 0.5× (better) |
| EV/EBITDA | – | 71.9× |
| Fair value | $92.16 | $32.21 |
| Margin of safety | −6.4% (better) | −46.1% |
| Growth | ||
| Revenue growth (TTM) | 56.8% (better) | 5.3% |
| Revenue growth, 5Y average | 3.7% (better) | −3.0% |
| Net income growth (TTM) | 109% (better) | 22.0% |
| EPS growth (TTM) | 111% (better) | 23.7% |
| EPS growth, 5Y average | 23.3% (better) | 15.8% |
| Profitability | ||
| Operating margin | – | −18.3% |
| Net margin | 2486% (better) | 16.1% |
| Return on equity | 7.8% (better) | 0.96% |
| Return on invested capital | – | −0.96% |
| Financial health | ||
| Debt / equity | 0.16 | – |
| Interest coverage | – | −1.0× |
| Altman Z-score | 1.06 | 1.67 (better) |
| Piotroski F-score | 8 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 4.3% (better) | 0.00% |
| Payout ratio | 141% | – |
| Years of dividend growth | 4 (better) | 0 |
| Dividend growth, 5Y average | 4.8% | – |
| Buyback yield | 7.1% | – |
| Shareholder yield | 11.5% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 103% | 3.8% |
| Held by insiders | 1.5% | 85.9% |
| Insider net buying, 12 months | −$9.6M | $7.8M (better) |
| Superinvestors holding | 2 | – |
| Short interest, % of float | 5.6% | 1.7% |
Go deeper
- CPT stock overview
- CPT income statement
- CPT valuation and score
- TCI stock overview
- TCI income statement
- TCI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.